Karine Egan

1.1k total citations
13 papers, 897 citations indexed

About

Karine Egan is a scholar working on Pharmacology, Genetics and Genetics. According to data from OpenAlex, Karine Egan has authored 13 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Genetics and 3 papers in Genetics. Recurrent topics in Karine Egan's work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Karine Egan is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Karine Egan collaborates with scholars based in United States, United Kingdom and Ireland. Karine Egan's co-authors include Garret A. FitzGerald, John A. Lawson, Beverley Koller, Emer M. Smyth, Susanne Fries, Daniel J. Rader, Miao Wang, Margaret B. Lucitt, Alicia Zukas and Ellen Puré and has published in prestigious journals such as Science, Circulation and Blood.

In The Last Decade

Karine Egan

13 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Egan United States 10 389 209 203 189 162 13 897
A J Marcus United States 7 251 0.6× 206 1.0× 185 0.9× 296 1.6× 58 0.4× 10 1.0k
Lenore B. Safier United States 10 196 0.5× 307 1.5× 177 0.9× 241 1.3× 64 0.4× 12 1.2k
Ugo Cavallari Italy 16 148 0.4× 191 0.9× 115 0.6× 428 2.3× 148 0.9× 30 967
P. V. Halushka United States 12 177 0.5× 192 0.9× 133 0.7× 105 0.6× 30 0.2× 27 672
Thomas A. Morinelli United States 12 151 0.4× 234 1.1× 69 0.3× 143 0.8× 62 0.4× 18 729
Dolgor Baatar Japan 18 409 1.1× 414 2.0× 86 0.4× 62 0.3× 209 1.3× 27 1.4k
Concetta Di Febbo Italy 18 110 0.3× 215 1.0× 49 0.2× 255 1.3× 54 0.3× 31 1.0k
M. Goerig Germany 13 234 0.6× 247 1.2× 168 0.8× 37 0.2× 102 0.6× 28 678
Nada Cordasic Germany 21 66 0.2× 299 1.4× 91 0.4× 306 1.6× 55 0.3× 48 1.0k
Ferhana Y. Ali United Kingdom 8 115 0.3× 224 1.1× 79 0.4× 224 1.2× 25 0.2× 8 647

Countries citing papers authored by Karine Egan

Since Specialization
Citations

This map shows the geographic impact of Karine Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Egan more than expected).

Fields of papers citing papers by Karine Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Egan. The network helps show where Karine Egan may publish in the future.

Co-authorship network of co-authors of Karine Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Egan. A scholar is included among the top collaborators of Karine Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Egan. Karine Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
4.
Zhou, Weisong, Koichi Hashimoto, Kasia Goleniewska, et al.. (2007). Prostaglandin I2 Analogs Inhibit Proinflammatory Cytokine Production and T Cell Stimulatory Function of Dendritic Cells. The Journal of Immunology. 178(2). 702–710. 133 indexed citations
5.
Goldsby, Jennifer S., et al.. (2007). Prostacyclin receptor signaling and early embryo development in the mouse. Human Reproduction. 22(11). 2851–2856. 21 indexed citations
6.
Rodrı́guez, Luis A. Garcı́a, Karine Egan, & Garret A. FitzGerald. (2007). Traditional Nonsteroidal Anti-Inflammatory Drugs and Postmenopausal Hormone Therapy: A Drug–Drug Interaction?. PLoS Medicine. 4(5). e157–e157. 15 indexed citations
7.
Egan, Karine & Garret A. FitzGerald. (2006). Eicosanoids and the Vascular Endothelium. Handbook of experimental pharmacology. 189–211. 28 indexed citations
8.
Ali, Ferhana Y., Karine Egan, Garret A. FitzGerald, et al.. (2005). Role of Prostacyclin versus Peroxisome Proliferator-Activated Receptor β Receptors in Prostacyclin Sensing by Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 34(2). 242–246. 79 indexed citations
9.
Egan, Karine, John A. Lawson, Susanne Fries, et al.. (2005). Cyclooxygenase-2-Derived Prostacyclin Confers Atheroprotection on Female Mice. Obstetrical & Gynecological Survey. 60(5). 309–310. 4 indexed citations
10.
Egan, Karine, Miao Wang, Margaret B. Lucitt, et al.. (2005). Cyclooxygenases, Thromboxane, and Atherosclerosis. Circulation. 111(3). 334–342. 166 indexed citations
11.
Hashimoto, Koichi, Barney S. Graham, Mark W. Geraci, et al.. (2004). Signaling through the Prostaglandin I2Receptor IP Protects against Respiratory Syncytial Virus-Induced Illness. Journal of Virology. 78(19). 10303–10309. 40 indexed citations
12.
Egan, Karine, John A. Lawson, Susanne Fries, et al.. (2004). COX-2-Derived Prostacyclin Confers Atheroprotection on Female Mice. Science. 306(5703). 1954–1957. 350 indexed citations
13.
Ide, Tomomi, et al.. (2003). Activation of nuclear receptors by prostaglandins. Thrombosis Research. 110(5-6). 311–315. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A J Marcus Breakdown of academic impact, for papers by Lenore B. Safier Breakdown of academic impact, for papers by Ugo Cavallari Breakdown of academic impact, for papers by P. V. Halushka Breakdown of academic impact, for papers by Thomas A. Morinelli Breakdown of academic impact, for papers by Dolgor Baatar Breakdown of academic impact, for papers by Concetta Di Febbo Breakdown of academic impact, for papers by M. Goerig Breakdown of academic impact, for papers by Nada Cordasic Breakdown of academic impact, for papers by Ferhana Y. Ali
Rankless by CCL
2026